Showing results (1-10 of 34) with videos related to
Sort By:
Pageof 4
Neurobiology of Aging|April 15, 2014
Raloxifene activates G protein-coupled estrogen receptor 1/Akt signaling to protect dopamine neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine miceMélanie Bourque, Marc Morissette, Thérèse Di PaoloBehavioural Brain Research|September 18, 2017
The plasmalogen precursor analog PPI-1011 reduces the development of L-DOPA-induced dyskinesias in de novo MPTP monkeysMélanie Bourque, Laurent Grégoire, Thérèse Di PaoloNeuropharmacology|April 13, 2018
Repurposing sex steroids and related drugs as potential treatment for Parkinson's diseaseMélanie Bourque, Marc Morissette, Thérèse Di PaoloNeuropharmacology|April 21, 2015
Neuroprotection in Parkinsonian-treated mice via estrogen receptor α activation requires G protein-coupled estrogen receptor 1Mélanie Bourque, Marc Morissette, Thérèse Di PaoloNeuroscience and Biobehavioral Reviews|November 25, 2023
Neuroactive steroids and Parkinson's disease: Review of human and animal studiesMélanie Bourque, Marc Morissette, Thérèse Di PaoloAndrogens: Clinical Research and Therapeutics|January 13, 2022
Androgens and Parkinson's Disease: A Review of Human Studies and Animal ModelsMélanie Bourque, Denis Soulet, Thérèse Di PaoloFrontiers in Neuroendocrinology|March 6, 2012
Signaling pathways mediating the neuroprotective effects of sex steroids and SERMs in Parkinson's diseaseMélanie Bourque, Dean E Dluzen, Thérèse Di PaoloNeuropharmacology|February 29, 2012
Sex and temporally-dependent effects of methamphetamine toxicity on dopamine markers and signaling pathwaysMélanie Bourque, Dean E Dluzen, Thérèse Di PaoloFrontiers in Neuroendocrinology|May 5, 2009
Neuroprotective actions of sex steroids in Parkinson's diseaseMélanie Bourque, Dean E Dluzen, Thérèse Di PaoloFrontiers in Endocrinology|June 2, 2012
Male/Female differences in neuroprotection and neuromodulation of brain dopamineMélanie Bourque, Dean E Dluzen, Thérèse Di PaoloPageof 4